Allergan Aesthetics redefines skin quality communication with launch of Skin Quality Index

Join Pharma | Login

	Editorial


	A GENUINE GRIEVANCE AGAINST JAKS
	Wednesday, March 11, 2026
	The Tamil Nadu Chemists and Druggists Association has recently lodged a complaint with the Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing agency of Pradhan Mantri Bhartiya
	Past Editorial...

TODAY'S NEWS


16:00 [IST]	Allergan Aesthetics redefines skin quality communication with launch of Skin Quality Index
15:40 [IST]	ASPA–CRISIL “State of Counterfeiting in India 2025” report reveals counterfeit medicines account for around 28% of the market
15:00 [IST]	Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease
14:50 [IST]	IIT Roorkee inaugurates Ashok Soota Molecular Medicine Facility at BSBE to advance translational biomedical research
14:40 [IST]	Pulse of Positivity Health and Wellness Summit 2026 brings policymakers, doctors, to shape the future of health in India
14:30 [IST]	Lupin and Zydus ink licensing agreement to co-market innovative semaglutide injection in India

more news >>

TOP NEWS


08:00 [IST]	CDSCO delegates powers to issue test license and NOC for veterinary drugs to Zonal Offices
08:00 [IST]	Draft Rules mandating manufacturers to notify every product update will boost transparency & responsibility: Expert
08:00 [IST]	FDI equity inflow into pharma sector grows 74% in first nine months of FY26
08:00 [IST]	West Asia war drives Indian hospitals to roll out AI-driven remote monitoring for international oncology patients
08:00 [IST]	Genomics to touch every branch of medicine ranging from oncology & rare diseases to infectious diseases: Expert
08:00 [IST]	DTAB recommends amendment of Schedule K to allow only unflavoured nicotine gums sold under exemption

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Study affirms superiority of iMDx GraftAssure assay’s proprietary dd-cfDNA combination model score
17:00 [IST]	US FDA clears Unixell Biotech’s IND for allogeneic iPSC-derived cell therapy, UX-GIP001 for focal epilepsy
16:15 [IST]	Maharashtra govt forms Committee to give autonomy to two govt hospitals in Mumbai and Nagpur
13:45 [IST]	Tracky expands India’s connected CGM ecosystem through strategic digital health collaborations with TatvaCare
12:50 [IST]	Vista Imaging, Medikabazaar and United Imaging bring advanced 640-slice AI powered CT scanner to Hyderabad
12:30 [IST]	Dr Reddy’s Labs hosts fourth edition of Dr Anji Reddy Memorial Lecture reinforcing need to advance science and research for future healthcare

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

Top 30 pharma companies post 12% revenue growth in first nine months, net profit up only by 2.8% US FDA ANDA Approvals for Indian Companies & Subsidiaries - February, 2026 USFDA Warning Letters Recently Posted For February 2026 USFDA Warning Letters Recently Posted For January 2026 iguratimod 25 mg tablet

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers